Cargando…
Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled Trial
BACKGROUND: Poor adherence to medications is a global public health concern with substantial health and cost implications, especially for chronic conditions. In the USA, poor adherence is estimated to cause 125,000 deaths and cost $US100 billion annually. The most successful adherence-promoting stra...
Autores principales: | Bilger, Marcel, Wong, Tina T., Lee, Jia Yi, Howard, Kaye L., Bundoc, Filipinas G., Lamoureux, Ecosse L., Finkelstein, Eric A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885505/ https://www.ncbi.nlm.nih.gov/pubmed/31317511 http://dx.doi.org/10.1007/s40258-019-00497-0 |
Ejemplares similares
-
Study on Incentives for Glaucoma Medication Adherence (SIGMA): study protocol for a randomized controlled trial to increase glaucoma medication adherence using value pricing
por: Bilger, Marcel, et al.
Publicado: (2016) -
Trial to Incentivise Adherence for Diabetes (TRIAD): study protocol for a randomised controlled trial
por: Bilger, Marcel, et al.
Publicado: (2017) -
Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs
por: Wong, William Bruce, et al.
Publicado: (2023) -
Process- and Outcome-Based Financial Incentives to Improve Self-Management and Glycemic Control in People with Type 2 Diabetes in Singapore: A Randomized Controlled Trial
por: Bilger, Marcel, et al.
Publicado: (2021) -
A prospective cohort study assessing aggressive interventions at the end-of-life among patients with solid metastatic cancer
por: Malhotra, Chetna, et al.
Publicado: (2022)